CAPR Competitors & Alternatives
Compare Capricor Therapeutics Inc with similar stocks in the same industry
Biotechnology
CAPR
Main Stock$8.47
-11.12%
Tradestie Score
28
Market Cap
$357.51M
Revenue Growth
-7.9%
Analyst Upside
+221.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Cell Therapy
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
+0.04%
|
$683.46M | - | 49 | Compare |
|
ANL
ANL
|
$9.97
-6.03%
|
$677.47M | - | 48 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$8.85
-3.59%
|
$665.30M | 10.1 | 46 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$14.95
-4.57%
|
$626.91M | - | 35 | Compare |
|
SVRA
Savara Inc.
|
$4.43
-4.63%
|
$611.84M | - | 56 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
+0.04%
|
$608.81M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$7.88
-3.67%
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.55
-0.85%
|
$540.97M | - | 34 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.31
+2.53%
|
$529.35M | 9.7 | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.75
-2.51%
|
$512.39M | - | 37 | Compare |
More CAPR Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry